Projects / Programmes
Keratin cytoskeleton dynamics and disease phenotype development
Code |
Science |
Field |
Subfield |
3.07.00 |
Medical sciences |
Metabolic and hormonal disorders |
|
Code |
Science |
Field |
B220 |
Biomedical sciences |
Genetics, cytogenetics |
B210 |
Biomedical sciences |
Histology, cytochemistry, histochemistry, tissue culture |
B630 |
Biomedical sciences |
Dermatology, venereology |
EBS, mutations, keratin, intermediate filaments, cytoskeleton, GFP, microscopy
Researchers (4)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
21039 |
PhD Mojca Gabrovšek |
Biochemistry and molecular biology |
Researcher |
2002 - 2004 |
8 |
2. |
18529 |
Dubravka Germ |
|
Researcher |
2002 - 2004 |
0 |
3. |
06135 |
PhD Radovan Komel |
Biochemistry and molecular biology |
Researcher |
2002 - 2004 |
1,053 |
4. |
14305 |
PhD Mirjana Liović |
Metabolic and hormonal disorders |
Head |
2002 - 2004 |
146 |
Organisations (1)
Abstract
Although much is known about the molecular defects underlying human hereditary skin disorders caused by keratin intermediate filament deficiency, little progress has been made in defining the mechanism(s) of disease phenotype development. The goal of this project is to study the cytoskeleton dynamics of healthy epithelial cell lines grown in tissue culture, and to use this information to identify the processes giving rise to the pathological phenotype in mutants, i.e. cells that express mutated keratins. For this purpose epidermolysis bullosa simplex (EBS) and keratins 5 and 14 (K5/K14) were chosen as a model system, as EBS is one of the best documented hereditary skin disorders.